covid_cell_1_20’s weekly COVID-19 news round-up

pharmafile | June 2, 2021 | News story | Research and Development  

The past week has been a mixed bag when it comes to COVID-19 news. The EU is suing AstraZeneca over its failure to deliver on its vaccine contract, and doctor vigilance has been urged by experts after rare instances of stroke following the AstraZeneca vaccines. On the positive side of things, the Sanofi-GSK COVID-19 vaccine has begun its Phase III trial, a COVID-fighting herbal supplement has launched, and Janssen’s one-shot vaccine has been approved by the MHRA.

 1. Janssen’s one-shot COVID vaccine approved by MHRA – Published 28/05/2021

The MHRA has approved the use of Janssen’s one-shot COVID-19 vaccine in the UK, becoming the fourth jab approved for use.

 2. First COVID-fighting herbal supplement launched – Published 27/05/21

 The first herbal supplement shown in clinical trials to prevent COVID-19 symptoms from deteriorating has been launched by Swiss Pharmacan AG.

 3. EU: Fine AstraZeneca €10 per dose for COVID-19 vaccine delay – Published – 28/05/21

The EU is suing AstraZeneca in a Brussels court over its failure to deliver on its vaccine contract.

 4. Sanofi-GSK Phase III trial begins for COVID-19 vaccine – Published 27/05/21

Sanofi and GSK have begun their Phase III clinical study to assess the safety, efficacy, and immunogenicity of their COVID-19 vaccine today.

 5. Doctor vigilance urged for rare instances of stroke following COVID-19 vaccinations – Published 26/05/21

Doctors have been urged to be vigilant for signs of stroke after three rare instances have occurred in Oxford-AstraZeneca patients.

Related Content

No items found

Latest content